Displaying items by tag: Health

Keir Starmer has announced plans to abolish NHS England, aiming to cut bureaucracy and redirect funds to frontline healthcare. Calling it an ‘arms-length body’, he argued that scrapping it would eliminate duplication, saving money for nurses and patient care. Health secretary Wes Streeting acknowledged that up to 10,000 jobs could be cut, but said reform was necessary to reduce inefficiency. NHS England, established in 2013, oversees daily NHS operations with a £168 million budget. Last month, its chief executive Amanda Pritchard stepped down, reflecting mounting pressures. Starmer’s broader government efficiency plan includes AI-driven reforms to streamline state functions, aiming to save £45 billion, and to cut compliance costs for businesses by 25%. He criticised the state as overstretched and ineffective, promising to reduce regulatory burdens. Streeting called the move the ‘final nail in the coffin’ of the ‘disastrous’ 2012 NHS reorganisation, pledging to empower healthcare workers and shorten waiting times.

A medical milestone has been achieved: the first patient implanted with a durable artificial heart has been discharged from hospital. BiVACOR, a titanium mechanical blood pump, was successfully implanted in a man suffering from severe heart failure. Performed at St Vincent’s Hospital in Sydney, the six-hour surgery marked a breakthrough in cardiac care. Designed to function indefinitely, BiVACOR operates using magnets to eliminate mechanical wear. Queensland-born inventor Daniel Timms spent years developing the device, inspired by childhood experiences working with his father, who later died of heart failure. The patient, previously too weak to walk, lived with the device for over 100 days before receiving a human heart transplant. Doctors anticipate BiVACOR could eventually replace the need for human donors. With more implants planned, this innovation offers new hope to those awaiting transplants.

Scientists at the University of Cambridge have discovered how aspirin may help prevent cancer from spreading. Their research suggests that the drug enhances the immune system’s ability to fight cancer by stopping platelets from suppressing T-cells, the body’s natural defence against cancer. When cancer cells break away from a tumour, they try to spread elsewhere in the body - a process called metastasis, which causes most cancer deaths. Normally, T-cells can destroy these wandering cancer cells. However, platelets, which help stop bleeding, interfere with T-cell activity, allowing cancer to spread. Aspirin appears to disrupt this process, restoring the immune system’s ability to attack cancer. While these findings are promising, scientists caution against self-medicating with aspirin, as it carries risks such as internal bleeding. Clinical trials are ongoing to determine which patients may benefit. Researchers hope this breakthrough will eventually lead to safer, more targeted treatments that mimic aspirin’s benefits without its risks.

A growing number of qualified GPs in England are unable to find work, with some resorting to jobs such as Uber driving to pay their bills. This crisis has been blamed on chronic underfunding and the rising costs of running GP practices, which has left many surgeries without the resources to hire doctors. A new survey by the British Medical Association found that one in five GPs is considering leaving the profession, while nearly half of those surveyed are looking for work outside the NHS. Some are seeking GP roles abroad, while others are considering leaving healthcare altogether. The government has pledged £889 million to reduce administrative burdens and expand GP recruitment programs, but experts warn this is not a long-term solution. Many doctors remain concerned that rising employer national insurance costs will further squeeze GP practices, potentially leading to a mass exodus from the profession. With demand for GP appointments at an all-time high, medical professionals are warning that unless core funding is significantly increased, the NHS could face a two-tier system, similar to what has happened in dentistry, where more doctors turn to private healthcare instead of the NHS. See

The Isle of Man is on course to become the first place in the British Isles to legalise assisted dying for terminally ill adults, as its parliament enters the final stages of debate on the legislation. If passed, the law would allow people over 18 with a prognosis of  less than twelve months to live to end their own lives under strict medical supervision. The proposal has sparked strong debate, with supporters arguing it grants dignity to those facing unbearable suffering, while opponents, including some doctors, fear it could lead to coercion and an expansion of euthanasia laws in the future. The UK, Scotland, and Jersey are also considering similar legislation, though their proposals differ in residency requirements and medical oversight. Some doctors on the Isle of Man have warned they may leave the profession if the law is enacted, while others see it as a necessary step for those suffering from painful, terminal illnesses.

A 52-year-old man has reportedly overcome a fifteen-year cocaine addiction after receiving weight-loss injections containing semaglutide. The drug, commonly used to treat obesity and diabetes, is believed to target the brain’s hunger and reward centres, reducing cravings not only for food but also for addictive substances. This first-of-its-kind case aligns with recent studies suggesting semaglutide could help treat addiction, including reducing alcohol consumption and smoking habits. Some researchers have even dubbed it a 'fountain of youth', as it has been linked to lowered heart attack risk, improved fertility, and slowed ageing markers. The man, who previously struggled with depression,  anxiety, and failed addiction treatments, sought help for both weight and drug dependency. Within twelve weeks, his focus shifted from drug use to exercise, showing improved physical health and self-esteem. Experts suggest semaglutide could be a promising treatment for addiction; however, further long-term studies are needed.

After being admitted to hospital on 14 February, Pope Francis has developed pneumonia in both lungs, and his condition remains ‘complex’. The 88-year-old pontiff has been battling a respiratory infection for over a week. A follow-up CT scan confirmed bilateral pneumonia, prompting adjustments to his treatment. Despite the serious nature of his illness, the Vatican reports that he remains in good spirits, spending time reading, resting, and praying. Francis' history of lung complications, including pleurisy and a partial lung removal in his youth, makes him particularly vulnerable to such infections. His illness has raised concerns over the upcoming Holy Year, a major Catholic ‘jubilee’ event expected to draw millions to Rome in 2025; uncertainty looms over his ability to fulfil his demanding schedule. See

Donald Trump’s reinstatement of the Global Gag Rule (GGR) has sparked widespread concern among activists and NGOs, who warn it will severely restrict healthcare access for women worldwide. The policy bars organisations receiving US funding from providing or advocating for abortion, even with their own funds. Many healthcare groups now face the impossible choice of losing critical financial support or restricting life-saving care. The impact is expected to be devastating. One NGO estimates that there will be 2.4 million unintended pregnancies and increased maternal deaths due to unsafe abortions. In Zimbabwe alone, service cutbacks will result in 460,000 unintended pregnancies and 1,400 preventable maternal deaths. The rule has also led to widespread clinic closures, reducing access to contraception, maternal care, and HIV testing. With US foreign aid frozen and USAID dismantled, the humanitarian fallout is severe.

Hundreds of thousands of women in the UK will be screened for breast cancer using AI technology in a groundbreaking trial designed to reduce waiting times and improve early detection. The £11 million trial will involve nearly 700,000 patients, replacing one of the two radiologists typically used to review mammograms with AI. Experts believe AI could increase accuracy and speed up diagnoses, allowing radiologists to focus on other areas of patient care. The trial will take place in thirty sites nationwide, with different AI technologies being tested to determine the most effective. Smaller studies have already suggested that AI may be better than human doctors at detecting breast cancer from mammograms. However, with a 40% shortfall in consultant radiologists expected by 2028, medical leaders emphasise the need for continued investment in screening services. Health secretary Wes Streeting, himself a cancer survivor, has pledged to prioritise early detection and patient care in the upcoming National Cancer Plan.

Uganda, in partnership with the WHO and other health organisations, has launched its first-ever vaccine trial for the Sudan strain of Ebola. The trial began just days after a nurse succumbed to the virus, with additional cases confirmed among his relatives. Researchers at Makerere University and the Uganda Virus Research Institute expedited the process, ensuring compliance with ethical and regulatory standards. The candidate vaccine, donated by IAVI and funded by international partners, aims to improve pandemic preparedness. Over 2,000 doses are available, though the manufacturer remains undisclosed. Uganda has a history of Ebola outbreaks, including a deadly 2000 epidemic. Contact tracing remains essential in containing the disease. This outbreak comes amid US funding freezes following the Trump administration’s withdrawal from the WHO. The region has also faced recent outbreaks of Marburg virus in Tanzania and Rwanda. Officials hope the vaccine will be a breakthrough in combating future Ebola epidemics.